Media & Insights

Boehringer Ingelheim BioXcellence™’s hub for the latest news, whitepapers and further material for download.

As one of the leading companies in biopharmaceutical contract manufacturing, we're always looking to the future – analyzing trends and embracing disruptive technologies. From industry insights to the latest updates about our capabilities, facilities and global business, this is your go-to source for staying informed about Boehringer Ingelheim BioXcellence™. Explore our stories and insights below.

Improving commercial bioprocess performance with digital process models

By applying data-driven modeling, Boehringer Ingelheim BioXcellence™ was able to implement low-risk process improvements in commercial biopharmaceutical manufacturing without additional experiments. In this case study we explain how.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/ai-bioprocess-optimization "Read more about "Improving commercial bioprocess performance with digital process models""/index.html)

Boehringer Ingelheim BioXcellence™: 2025 Highlights

2025 brought change to the biologics industry and we moved with it. With a stronger global production network, advanced digital capabilities, and deeper customer partnerships, we delivered progress as a trusted CDMO partner. Discover the highlights.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/cdmo-insights-2025-bioxcellence "Read more about "Boehringer Ingelheim BioXcellence™: 2025 Highlights""/index.html)

On‑demand: 2026 biopharma capabilities update

Explore how Boehringer Ingelheim BioXcellence™ collaborates with partners to drive large‑molecule innovation with a global production network, state‑of‑the‑art technologies and trusted contract manufacturing expertise.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/capabilities-update-march-26-bioxcellence "Read more about "On‑demand: 2026 biopharma capabilities update""/index.html)

How biological medicines are made

Take a look inside the step‑by‑step process of biopharmaceutical production – from the first modified cells to the final sterile drug product.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/how-biologics-are-made-bioxcellence "Read more about "How biological medicines are made""/index.html)

Next Generation Manufacturing of biologics: efficiency, sustainability and digital innovation

In this whitepaper we explore how modern process models and digital tools are transforming biologics manufacturing – enabling greater scalability, speed, and sustainability.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/digital-bioproduction-bioxcellence "Read more about "Next Generation Manufacturing of biologics: efficiency, sustainability and digital innovation""/index.html)

On-demand webinar: 2025 biopharma capacity update

Discover how Boehringer Ingelheim BioXcellence™ drives success in mammalian and microbial biologics in the latest Outsourced Pharma Capacity Update. Learn more about our contract manufacturing services and global capacities.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/capacity-update-oct-25-bioxcellence "Read more about "On-demand webinar: 2025 biopharma capacity update""/index.html)

“Our experience and expertise as a biopharma pioneer sets us apart from other contract manufacturing organizations.”

Hear all about the strengths of our facility in Fremont, California, USA from Lilith Baczynski, U.S. Director of Boehringer Ingelheim BioXcellence™ in this interview.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/fremont-spotlight-bioxcellence "Read more about "“Our experience and expertise as a biopharma pioneer sets us apart from other contract manufacturing organizations.”""/index.html)

Partnership in action: Scaling up cell-free ADC manufacturing

Read this whitepaper to discover how we’re shaping commercial antibody-drug conjugate (ADC) production with cell-free technology and see how collaboration drives progress in cancer care.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/adc-manufacturing "Read more about "Partnership in action: Scaling up cell-free ADC manufacturing""/index.html)

Webinar: Closing the scale-up gap with N-1 perfusion

In this webinar, Boehringer Ingelheim BioXcellence™ experts share insights into how N-1 perfusion strategies can help resolve common scale-up constraints in upstream commercial biologics manufacturing.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/n-1-perfusion-webinar-bioxcellence "Read more about "Webinar: Closing the scale-up gap with N-1 perfusion""/index.html)

How we’re bringing biologics to life

Boehringer Ingelheim BioXcellence™ is known for a collaborative approach to biologics contract manufacturing. In this interview, Andrea Rothmaler – Head of Boehringer Ingelheim BioXcellence™ – shares her perspective on what sets us apart.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/interview-rothmaler-bioxcellence "Read more about "How we’re bringing biologics to life""/index.html)

Boehringer Ingelheim and AnGes sign manufacturing agreement for HGF gene therapy product

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/hgf-gene-therapy-product "Read more about "Boehringer Ingelheim and AnGes sign manufacturing agreement for HGF gene therapy product""/index.html)

Why a worldwide production network supports flexibility and reliability

In a world of constant change, adapting to demand volatilities while maintaining reliable supply of biological medicines, is more critical than ever. Our large-scale mammalian cell culture network provides solutions that are flexible and reliable.

[Read more](/content/partnering/boehringer-ingelheim-bioxcellence/newsroom/supply-reliability-bioxcellence "Read more about "Why a worldwide production network supports flexibility and reliability""/index.html)